OptiNose, Inc. short interest in 2024
In 2024, OptiNose, Inc.'s disclosed short interest ran from 3.12% of shares outstanding on 12 Jan 2024 to 2.11% on 13 Dec 2024, a change of -1.01 percentage points. The year's high was 6.85% on 28 Jun 2024 and its low 2.11% on 13 Dec 2024, averaging 4.51% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 45.77 days on 31 Oct 2024. Full history: OptiNose, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024
2024 in figures
- Start of year
- 3.12% (12 Jan 2024)
- End of year
- 2.11% (13 Dec 2024)
- Change
- -1.01 pp
- High
- 6.85% (28 Jun 2024)
- Low
- 2.11% (13 Dec 2024)
- Average
- 4.51%
- Highest days to cover
- 45.77 (31 Oct 2024)
- SEC filings marked
- 10
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 3.12% | 13.33 | |
| 31 Jan 2024 | 3.02% | 12.80 | |
| 15 Feb 2024 | 3.20% | 11.94 | |
| 29 Feb 2024 | 2.86% | 5.82 | |
| 15 Mar 2024 | 2.84% | 3.84 | 10-K filed, results (8-K) |
| 28 Mar 2024 | 2.76% | 2.63 | |
| 15 Apr 2024 | 2.85% | 7.63 | |
| 30 Apr 2024 | 5.25% | 1.95 | results (8-K) |
| 15 May 2024 | 6.47% | 7.48 | results (8-K), 10-Q filed, results (8-K) |
| 31 May 2024 | 6.27% | 11.09 | |
| 14 Jun 2024 | 5.06% | 14.90 | |
| 28 Jun 2024 | 6.85% | 4.00 | |
| 15 Jul 2024 | 5.06% | 9.38 | |
| 31 Jul 2024 | 4.27% | 10.36 | |
| 15 Aug 2024 | 4.61% | 9.87 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 4.65% | 25.95 | |
| 13 Sep 2024 | 4.62% | 21.00 | |
| 30 Sep 2024 | 5.59% | 13.50 | |
| 15 Oct 2024 | 5.76% | 30.56 | |
| 31 Oct 2024 | 5.68% | 45.77 | |
| 15 Nov 2024 | 6.02% | 8.73 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 4.88% | 4.26 | |
| 13 Dec 2024 | 2.11% | 3.38 |
See also: OptiNose, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.